ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis.

@article{Urun2017ERCC1AA,
  title={ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis.},
  author={Y Yilmaz Urun and Jeffrey J Leow and Andr{\'e} Poisl Fay and Laurence K Albiges and Toni K Choueiri and Joaquim Bellmunt},
  journal={Critical reviews in oncology/hematology},
  year={2017},
  volume={120},
  pages={
          120-126
        }
}
BACKGROUND The predictive role of excision repair cross-complementing group 1 (ERCC1) as a predictive factor in patients with advanced urothelial cancer (AUC) treated with platinum-based treatment is not well defined. Here, we evaluate the role of ERCC1 in patients with AUC treated with platinum-based treatment. METHODS We performed comprehensive, systematic computerized search to identify relevant studies through Medline, Embase, Cochrane Controlled Trials Register (CCTR) databases and… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS